Use and Benefit of Neoadjuvant Versus Adjuvant Chemotherapy in Node-Negative, T1 Triple Negative Breast Cancer is a research paper published in Clinical Breast Cancer (2025). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Center for Advancing Translational Sciences
Grant: UL1 TR002556
National Institutes of Health
Grant: 5K12CA132783-08
Paul Calabresi Career Development Award for Clinical Oncology (K12)
NCI NIH HHS
Grant: K12 CA132783
NCATS NIH HHS
Grant: UM1 TR004400
Fields of Study
MeSH Terms
Keywords